The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects

This study highlights that antiplatelet agent prescriptions, specifically dual antiplatelet agent therapy, are at least suboptimal as well as in prescription continuity. Hospitalisations were frequent and were the main driver of the costs, accounting for 84% of the total costs for the Italian National Health System.